Ziheng He
Overview
Explore the profile of Ziheng He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li P, Kong D, Yang J, Cui S, Chen Q, Liu Y, et al.
Nanomaterials (Basel)
. 2025 Feb;
15(3).
PMID: 39940138
The advent of two-dimensional (2D) ferroelectrics offers a new paradigm for device miniaturization and multifunctionality. Recently, 2D α-InSe and related III-VI compound ferroelectrics manifest room-temperature ferroelectricity and exhibit reversible spontaneous...
2.
Zhou Q, Chen B, Xu Y, Wang Y, He Z, Cai X, et al.
J Ethnopharmacol
. 2023 Jul;
318(Pt A):116914.
PMID: 37451492
Ethnopharmacological Relevance: Fructus Gardeniae, with the effects of discharging fire, eliminating vexation, reducing fever and causing diuresis, and cooling blood to remove apthogentic heat, could be used to treat Parkinson's...
3.
Zhang W, Zeng L, Yu H, He Z, Huang C, Li C, et al.
Acta Biomater
. 2023 Jan;
158:163-177.
PMID: 36596433
Excessive production of reactive oxygen species (ROS) amplifies pro-inflammatory pathways and exacerbates immune responses, and is a key factor in the progression of osteoarthritis (OA). Therapeutic hydrogen gas (H) with...
4.
Liu Y, Yang P, Jia P, He Z, Luo H
PLoS One
. 2022 Sep;
17(9):e0273804.
PMID: 36107957
With the continuous development of deep learning, more and more domains use deep learning technique to solve key problems. The security issues of deep learning models have also received more...
5.
Ren D, Hua Y, Yu B, Ye X, He Z, Li C, et al.
Mol Cancer
. 2020 Feb;
19(1):31.
PMID: 32059674
After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced.
6.
Ren D, Hua Y, Yu B, Ye X, He Z, Li C, et al.
Mol Cancer
. 2020 Feb;
19(1):19.
PMID: 32000802
Immune checkpoint blockade targeting PD-1/PD-L1 has promising therapeutic efficacy in a variety of tumors, but resistance during treatment is a major issue. In this review, we describe the utility of...